ADMA
$10.68-0.47%
ADMA Biologics IncStock · HealthcareRussell 2000 0.06%Nasdaq Composite 0.005%Russell 3000 0.003%US Stock Market 0.003%
ADMA financial statements
The full income statement, balance sheet, and cash-flow statement for ADMA Biologics Inc (ADMA), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 233.1M2024-09 236.4M2024-12 237.6M2025-03 238.7M2025-06 238.6M2025-09 238.0M2025-12 238.2M2026-03 231.8M2026-06 224.0M-3.9% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 510M+19.6% | 426M+65.2% | 258M+67.6% | 154M+90.4% | 80.9M+91.7% | |
| 293M+33.3% | 220M+146.8% | 88.9M+152.2% | 35.3M+2906.4% | 1.17M+106.2% | ||
| Cost of revenue | 217M+5.1% | 207M+22.2% | 169M+42.5% | 119M+48.9% | 79.8M+30.1% | |
| 101M+25.8% | 80.6M+19.7% | 67.3M-9.8% | 74.6M+25.3% | 59.5M+29.9% | ||
| Research & development | 4.76M+162.7% | 1.81M-45.1% | 3.30M-8.7% | 3.61M-0.9% | 3.65M-38.3% | |
| Selling, general & administrative | 91.6M+23.5% | 74.1M+25.6% | 59.0M+12.5% | 52.5M+22.3% | 42.9M+22.4% | |
| Amortization of intangibles | 144K-62.9% | 388K-46.4% | 724K+1.3% | 715K+0.0% | 715K-0.0% | |
| Operating income | 191M+37.7% | 139M+542.5% | 21.6M+155.0% | -39.4M+32.6% | -58.4M+10.1% | |
| Interest expense | 7.11M-49.0% | 13.9M-44.3% | 25.0M+29.8% | 19.3M+47.7% | 13.1M+8.9% | |
| Interest & investment income | 1.87M-10.8% | 2.10M+29.7% | 1.62M+3493.3% | 45.0K+28.6% | 35.0K-87.9% | |
| Other non-operating income | -212K-9.8% | -193K+32.8% | -287K+54.8% | -635K-152.0% | -252K+97.7% | |
| Pre-tax income | 183M+45.3% | 126M+545.2% | -28.2M+57.2% | -65.9M | — | |
| Income tax | 35.7M+149.6% | -72.0M | 0.00 | 0.00 | 0.00 | |
| Net income | 147M-25.7% | 198M+800.0% | -28.2M+57.2% | -65.9M+8.0% | -71.6M+5.4% | |
| $0.60-25.9% | $0.81+723.1% | -$0.13+60.6% | -$0.33+35.3% | -$0.51+42.0% | ||
| EPS (basic) | $0.62-27.1% | $0.85+753.8% | -$0.13+60.6% | -$0.33+35.3% | -$0.51+42.0% | |
| Weighted-avg shares (basic) | 238M+2.2% | 233M+4.1% | 224M+13.2% | 198M+41.8% | 140M+62.0% | |
| Weighted-avg shares (diluted) | 245M+0.6% | 243M+8.6% | 224M+13.2% | 198M+41.8% | 140M+62.0% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 467M+40.8% | 331M+28.9% | 257M-5.0% | 270M+29.5% | 209M+35.8% | ||
| Cash & equivalents | 87.6M-15.0% | 103M+100.9% | 51.4M-40.6% | 86.5M+69.4% | 51.1M-8.6% | |
| Accounts receivable | 158M+216.9% | 50.0M+82.3% | 27.4M+76.9% | 15.5M-45.7% | 28.6M+115.9% | |
| Inventory | 206M+21.3% | 170M-1.5% | 173M+5.9% | 163M+30.9% | 125M+53.0% | |
| Prepaid expenses | 7.46M-7.1% | 8.03M+50.5% | 5.33M+4.7% | 5.09M+17.4% | 4.34M+42.4% | |
| 624M+27.7% | 489M+48.5% | 329M-5.5% | 348M+26.1% | 276M+33.0% | ||
| Property, plant & equipment | 65.1M+18.9% | 54.7M+1.6% | 53.8M-7.6% | 58.3M+14.4% | 50.9M+22.5% | |
| Operating lease right-of-use | 6.65M-23.0% | 8.63M-10.4% | 9.63M-8.1% | 10.5M+44.4% | 7.26M+70.5% | |
| Goodwill | 3.53M+0.0% | 3.53M+0.0% | 3.53M+0.0% | 3.53M+0.0% | 3.53M+0.0% | |
| Intangible assets | 632K+37.4% | 460K-7.8% | 499K-50.7% | 1.01M-41.4% | 1.73M-29.3% | |
| Deferred tax assets | 73.3M-13.1% | 84.3M | 0.00 | — | — | |
| 69.5M+25.2% | 55.5M+11.5% | 49.8M+26.8% | 39.3M+29.3% | 30.4M+52.3% | ||
| Accounts payable | 22.5M+11.4% | 20.2M+29.1% | 15.7M+18.4% | 13.2M+6.4% | 12.4M+12.2% | |
| Deferred revenue | — | 143K-21.4% | 182K+27.3% | 143K+0.1% | 143K+0.0% | |
| Short-term & current debt | 2.81M | 0.00 | — | — | — | |
| Current lease liability | 1.10M-10.0% | 1.22M+16.6% | 1.04M+15.5% | 905K+53.1% | 591K+61.6% | |
| 147M+5.2% | 140M-28.0% | 194M-1.3% | 196M+45.5% | 135M+13.1% | ||
| Long-term debt | 69.3M-4.2% | 72.3M | — | — | — | |
| Deferred revenue (non-current) | 1.41M-9.2% | 1.55M-8.5% | 1.69M-7.8% | 1.83M-7.2% | 1.98M-6.7% | |
| Non-current lease liability | 6.65M-22.4% | 8.56M-12.5% | 9.78M-8.6% | 10.7M+43.4% | 7.46M+72.2% | |
| Operating lease liability (total) | 7.70M | — | — | — | — | |
| Other non-current liabilities | 0.00-100.0% | 360K-14.1% | 419K+19.7% | 350K-11.9% | 397K+624.0% | |
| 477M+36.8% | 349M+158.1% | 135M-11.0% | 152M+7.7% | 141M+60.0% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 24.0K+0.0% | 24.0K+4.3% | 23.0K+4.5% | 22.0K+12.4% | 19.6K+86.7% | |
| Additional paid-in capital | 671M+2.0% | 658M+2.5% | 641M+1.8% | 630M+13.9% | 553M+29.1% | |
| Retained earnings | -162M+47.6% | -309M+39.0% | -506M-5.9% | -478M-16.0% | -412M-21.0% | |
| Treasury stock | 32.1M | 0.00 | — | — | — | |
| Total liabilities & equity | 624M+27.7% | 489M+48.5% | 329M-5.5% | 348M+26.1% | 276M+33.0% | |
| Common shares issued | 240M+1.3% | 237M+11865.6% | 1.98M-99.1% | 222M+13.3% | 196M+86.7% | |
| Common shares outstanding | 238M+0.5% | 237M+4.7% | 226M+1.9% | 222M+13.3% | 196M+86.7% | |
| Shares outstanding (cover) | 238M+0.2% | 238M+4.1% | 228M+2.7% | 222M+13.4% | 196M+61.6% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 50.4M-57.5% | 119M+1248.5% | 8.80M+114.8% | -59.5M+47.0% | -112M-10.2% | ||
| Depreciation & amortization | 8.00M+3.9% | 7.70M+1.3% | 7.60M+18.8% | 6.40M+33.3% | 4.80M+50.0% | |
| Intangible amortization | 144K-62.9% | 388K-46.4% | 724K+1.3% | 715K+0.0% | 715K-0.0% | |
| Share-based compensation | 20.0M+47.1% | 13.6M+120.1% | 6.19M+18.6% | 5.21M+49.5% | 3.49M+22.2% | |
| Deferred income taxes | 11.0M+113.1% | -84.3M | 0.00 | 0.00 | — | |
| Change in receivables | 108M+380.2% | 22.6M+89.5% | 11.9M+191.2% | -13.1M-185.2% | 15.3M+57.1% | |
| Change in inventory | 36.2M+1456.4% | -2.67M-127.7% | 9.63M-75.0% | 38.6M-10.7% | 43.2M+51.7% | |
| Change in payables | 2.33M-43.9% | 4.15M+8.1% | 3.84M+379.9% | 800K-41.0% | 1.36M-28.6% | |
| -21.9M-155.3% | -8.57M-72.2% | -4.98M+64.2% | -13.9M-3.0% | -13.5M-6.2% | ||
| Capital expenditure | 22.6M+174.4% | 8.23M+72.4% | 4.77M-65.7% | 13.9M+3.0% | 13.5M+6.2% | |
| Free cash flow | 27.8M-74.8% | 110M+2641.3% | 4.03M+105.5% | -73.4M+41.7% | -126M-9.7% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | — | — | — | — | 0.00-100.0% | |
| -44.0M+24.5% | -58.3M-49.5% | -39.0M-135.8% | 109M-10.1% | 121M-15.9% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock issued | 0.00 | 0.00 | 0.00-100.0% | 64.6M-46.6% | 121M-7.7% | |
| Common stock repurchased | 31.9M | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -15.5M-130.0% | 51.8M+247.3% | -35.2M-199.3% | 35.4M+833.3% | -4.83M-116.6% | |
| Interest paid | 9.08M-14.9% | 10.7M-40.9% | 18.1M+30.1% | 13.9M+24.4% | 11.2M+8.7% | |
| Income taxes paid | 19.7M+109.6% | 9.39M | 0.00 | 0.00 | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 4.34B+6.6% | 4.08B+299.0% | 1.02B+33.8% | 763M+176.4% | 276M+35.0% | |
| P/E | 29.6×+43.4% | 20.6× | — | — | — | |
| P/S | 8.5×-10.9% | 9.6×+119.2% | 4.4×-25.5% | 5.9×+71.5% | 3.4×-29.6% | |
| P/B | 9.1×-22.1% | 11.7×+73.1% | 6.7×-11.3% | 7.6×+288.7% | 2.0×-15.6% | |
| P/FCF | 156.1×+323.2% | 36.9× | — | — | — | |
| Earnings yield | 3.4%-30.3% | 4.9% | — | — | — | |
| FCF yield | 0.64%-76.4% | 2.7% | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: ADMA’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ADMA filings on SEC EDGAR → Not investment advice.